[1]徐立, 丛伟红, 魏翠娥, 等. 维脑康对小鼠记忆障碍的影响[J]. 中药药理与临床, 2007, 23(6):60-62.
[2]徐立, 林成仁, 刘建勋, 等. 塞络通胶囊对多发梗死性痴呆大鼠认知功能障碍的干预作用 [J]. 中国中药杂志, 2012, 37(19):2943-2946.
[3]郑咏秋, 刘建勋, 徐立, 等. 维脑康及银杏总内酯对局灶性脑缺血再灌注自噬和神经发生作用研究 [J]. 中国中药杂志, 2013, 38(13):2182-2185.
[4]徐立, 刘建勋, 丛伟红, 等. 维脑康胶囊对慢性脑低灌注大鼠脑内胆碱能系统及清除自由基能力的影响 [J]. 中国中药杂志, 2008, 33(5):531-534.
[5]Liang J, Li F, Wei C, et al. Rationale and design of a multicenter, phase 2 clinical trial to investigate the efficacy of traditional Chinese medicine SaiLuoTong in vascular dementia [J]. J Stroke Cerebrovasc Dis, 2014, 23(10):2626-2634.
[6]Steiner GZ, Yeung A, Liu JX, et al. The effect of Sailuotong (SLT) on neurocognitive and cardiovascular function in healthy adults: a randomised, double-blind, placebo controlled crossover pilot trial [J]. BMC Complement Altern Med, 2016, 16(1):15.
[7]张颖, 刘建勋, 林力, 等. HPLC-ECD法测定大鼠血浆中银杏叶黄酮成分及药代动力学研究 [J]. 药物分析杂志, 2011, 31(1):10-14.
[8]张颖, 刘建勋, 林力, 等. 大鼠口服西红花苷-1后吸收入血成分及药动学 [J]. 中国药学杂志, 2012, 47(2):136-140.
[9]Zhang Y, Miao L, Lin L, et al. Repeated administration of Sailuotong, a fixed combination of Panax ginseng, Ginkgo biloba, and Crocus sativus extracts for vascular dementia, alters CYP450 activities in rats [J]. Phytomedicine, 2018, 38:125-134.
[10]Martignoni M, Groothuis GM, de Kanter R. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction [J]. Expert Opin Drug Metab Toxicol, 2006, 2(6):875-894.
[11]Fuhr U, Doehmer J, Battula N, et al. Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms [J]. Biochem Pharmacol, 1992, 43(2):225-235.
[12]Kobayashi K, Urashima K, Shimada N, et al. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat [J]. Biochem Pharmacol, 2002, 63(5):889-896.
[13]Matsubara T, Kim HJ, Miyata M, et al. Isolation and characterization of a new major intestinal CYP3A form, CYP3A62, in the rat [J]. J Pharmacol Exp Ther, 2004, 309(3):1282-1290.
[14]Zhou Y, Wang S, Ding T, et al. Evaluation of the effect of apatinib (YN968D1) on cytochrome P450 enzymes with cocktail probe drugs in rats by UPLC-MS/MS [J]. J Chromatogr B, 2014, 973C:68-75.
[15]Doroshyenko O, Rokitta D, Zadoyan G, et al. Drug cocktail interaction study on the effect of the orally administered lavender oil preparation silexan on cytochrome P450 enzymes in healthy volunteers [J]. Drug Metab Dispos, 2013, 41(5):987-993.
[16]McGinnity DF,Parker AJ,Soars M,et al.Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s[J].Drug Metab Dispos,2000,28(11):1327-1334.
[17]Schadel M, Wu D, Otton SV, et al. Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition [J]. J Clin Psychopharmacol, 1995, 15(4):263-269.
[18]Heizmann P, Eckert M, Ziegler WH. Pharmacokinetics and bioavailability of midazolam in man [J]. Br J Clin Pharmacol, 1983, 16 Suppl 1:43S-49S.
[19]张颖, 林力, 刘光宇, 等. 塞络通灌胃后人参皂苷在大鼠体内的药代动力学及脑分布研究 [J]. 中国中药杂志, 2014, 39(2):316-321.
[20]张颖, 林力, 任常英, 等. 中药复方塞络通中银杏内酯类成分的药代动力学及脑分布研究 [J]. 世界科学技术-中医药现代化, 2014, 16(7):1458-1464.
[21]Gaudineau C, Beckerman R, Welbourn S, et al. Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract [J]. Biochem Biophys Res Commun, 2004, 318(4):1072-1078. |